Clinical Trial Update: Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide plus R-CHOP as prophylaxis for CNS relapse in diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• R-CHOP

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN